Artificial Intelligence and Consumer Personalisation in the Nigerian Beverage Industry: Evidence from Nigerian Bottling Company Plc
AKSU Journal of Management Sciences · 27.02.2026 · 1 (1) · 30-43
DOI: 10.61090/aksujomas.11103 ↗Kurz gefasst
Fachartikel in der Zeitschrift AKSU Journal of Management Sciences, online erschienen am 27.02.2026. Verfasst von Raphael Augustine UDO.
Abstract (Originalsprache)
This study examined the effect of Artificial Intelligence (AI) enabled marketing practices on consumer personalisation in the Nigerian beverage industry, with specific reference to the Nigeria Bottling Company Plc in South-South Nigeria. Anchored on the Stimulus-Organism-Response (S-O-R) Theory, the Technology Acceptance Model, and Relationship Marketing Theory, the study conceptualised AI as an enabling marketing capability comprising machine learning, data analytics, predictive personalisation, automation, natural language processing, AI-driven content recommendation, and real-time responsiveness. A quantitative survey design was adopted, and data were collected from 400 consumers using a structured questionnaire. Real-time responsiveness emerged as the strongest predictor of consumer personalisation.
Zitieren
APA
UDO, R. A. (2026). Artificial Intelligence and Consumer Personalisation in the Nigerian Beverage Industry: Evidence from Nigerian Bottling Company Plc. AKSU Journal of Management Sciences, 1(1), 30-43. https://doi.org/10.61090/aksujomas.11103
Vancouver
UDO RA. Artificial Intelligence and Consumer Personalisation in the Nigerian Beverage Industry: Evidence from Nigerian Bottling Company Plc. AKSU Journal of Management Sciences. 2026;1(1):30-43. doi:10.61090/aksujomas.11103
BibTeX
@article{UDO2026,
author = {UDO, Raphael Augustine},
title = {Artificial Intelligence and Consumer Personalisation in the Nigerian Beverage Industry: Evidence from Nigerian Bottling Company Plc},
journal = {AKSU Journal of Management Sciences},
year = {2026},
volume = {1},
number = {1},
pages = {30--43},
doi = {10.61090/aksujomas.11103}
}
EUVIMED